clock menu more-arrow no yes mobile

Filed under:

New York commission clears Nate Diaz to compete at UFC 244

UFC 244 Masividal v Diaz Press Conference Photo by Michael Owens/Zuffa LLC/Zuffa LLC

UFC star Nate Diaz is now fully cleared to fight Jorge Masvidal at UFC 244.

Three days after Diaz was exonerated by the UFC and its anti-doping parter, U.S. Anti-Doping Agency (USADA), the state athletic commission overseeing Saturday’s event has also signed off on Diaz’s participation.

Officially, the New York State Athletic Commission had the final say on whether to license Diaz for the pay-per-view card at Madison Square Garden. After a review of the documentation showing the Stockton, Calif., native didn’t commit an anti-doping violation, the commission has given the green light.

”Based on the full lab and medical analyses provided by USADA and reviewed by the commission, Nate Diaz is not disqualified from participating in the upcoming UFC 244 event,” read the statement provided to MMA Fighting by an NYSAC spokesperson. “As with all fighters proposed for the UFC 244 event, the New York State Athletic Commission licensing process continues through the weigh-in and pre-fight physical.”

What that means is that Diaz still has a few hoops to clear before he steps into the cage. He’ll need to be medically cleared to fight by NYSAC doctors and make the 171-pound limit for the bout, which is to be contested for the “BMF” title created by the UFC.

UFC executives strenuously defended Diaz after he reported failing a drug test in advance of the fight, setting abuzz the news cycle. Diaz vowed not to compete unless his name was cleared and said he’d been told to keep his positive test quiet, which prompted him to declare, “Your all on steroids not me.”

A test of Diaz’s supplements revealed trace metabolites of LGD-4033, a selective androgen receptor modulator (SARM) that’s previously popped up in USADA cases involving contaminated supplements. Diaz’s positive ultimately was traced back to a “vegan, plant-based daily multivitamin.” UFC officials announced there was “unequivocally no appreciable performance enhancing or therapeutic benefit”

According to the statement from the UFC, the level of LGD-4033 in Diaz’s system was “roughly 10,000 times lower than one LGD-4033 therapeutic dose.”

Diaz is scheduled to return to the cage two months after stopping ex-champ Anthony Pettis at UFC 241. The fight marked his first bout in three years after losing a decision to Conor McGregor in a blockbuster rematch. Following his win over Pettis, he called out Masvidal, who eagerly accepted the bout.

Sign up for the newsletter Sign up for the MMA Fighting Daily Roundup newsletter!

A daily roundup of all your fighting news from MMA Fighting